Telix Announces Reorganisation to Deliver on Strategic Priorities, Business News
Business News

Telix Announces Reorganisation to Deliver on Strategic Priorities, Business News

Business new tamfitronics MELBOURNE, Australia, Aug. 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces new leadership appointments as part of an internal reorganisation to align its operations across four business units, reflecting its focus as a therapeutics-led radiopharmaceutical company committed to precision oncology. The updated business model comprises: Therapeutics, Precision Medicine (Diagnostics), Lightpoint (Medtech) and Telix Manufacturing Solutions (TMS). As part of this initiative, the Company announces three leadership changes: Richard Valeix, Chief Executive Officer, Telix Therapeutics (formerly Group Chief Commercial Officer)leading the Company's therapeutic pipeline commercialisation and business development; Kevin Richardson, Chief...
Continue reading